Lotus Biotech Development Corp. - FORM 10-Q - EX-32.1 - SARBANES-OXLEY 906 CERTIFICATION - CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICER. - November 13, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Lotus Biotech Development Corp.Financial_Report.xls
EX-31.1 - SARBANES-OXLEY 302 CERTIFICATION - PRINCIPAL EXECUTIVE AND PRINCIPAL FINANCIAL OFFICER. - Lotus Biotech Development Corp.exh31-1.htm
10-Q - STARFLICK.COM FORM 10-Q (9/30/2012). - Lotus Biotech Development Corp.sfc10q-9302012.htm

Exhibit 32.1





CERTIFICATION PURSUANT TO
18 U.S.C. Section 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Starflick.com (the “Company”) on Form 10-Q for the period ended September 30, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, Zoltan Nagy, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
    
 
(2)
The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated this 9th day of November, 2012.


 
ZOLTAN NAGY
 
Zoltan Nagy
 
Chief Executive Officer and Chief Financial Officer




 
 

 








 
 
 

Lotus Biotech Development Corp. Reports